Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DNA polymerases involved in nuclear DNA synthesis are a group of essential enzymes responsible for the high-fidelity replication and repair of the nuclear genome (UniProt: P15884, P28908). The primary replicative enzymes include Polymerase alpha (Pol α), which initiates synthesis, and Polymerases delta (Pol δ) and epsilon (Pol ε), which catalyze the elongation of the lagging and leading strands, respectively (Nature Reviews Cancer, 2016). These enzymes utilize deoxyribonucleotide triphosphates (dNTPs) to synthesize DNA strands complementary to a template, ensuring the accurate transmission of genetic information during the S-phase of the cell cycle. In oncology, these polymerases are significant therapeutic targets for antimetabolite drugs, such as Cytarabine and Gemcitabine, which act as nucleoside analogs to inhibit polymerase activity or cause lethal chain termination in rapidly dividing malignant cells (StatPearls, 2023). Beyond replication, nuclear polymerases like Pol beta (Pol β) are critical for DNA repair pathways, such as base excision repair, which maintain genomic stability. Mutations in the proofreading domains of Pol δ and Pol ε are associated with hypermutated tumor phenotypes and hereditary cancer syndromes, making them important diagnostic and prognostic markers (PubMed: PMC4351158). Therapeutic challenges include the lack of specificity for cancerous versus healthy dividing cells, leading to significant side effects like myelosuppression.
Inhibition of DNA synthesis through competitive antagonism of natural deoxyribonucleotide triphosphates (dNTPs) and induction of DNA chain termination following incorporation into the nascent DNA strand.
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DNA polymerase (nuclear) (DNA Pol) (DNA Pol).